Mark Litton

Mark Litton

Chief Executive Officer bij ATHIRA PHARMA, INC.

Vermogen: 631 731 $ op 29-02-2024

56 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Mark J.
Litton
founded Lundbeck Seattle BioPharmaceuticals, Inc. Currently, he is President, Chief Executive Officer & Director at Athira Pharma, Inc. Dr. Litton is also on the board of Lumen Bioscience, Inc. Dr. Litton previously held the position of President & Chief Operating Officer at Alpine Immune Sciences, Inc., Manager-Business Development at Sirna Therapeutics, Inc., Vice President-Business Development of Celltech Group Plc, Vice President-Business Development of Chiroscience Group Plc, Secretary, Treasurer & Chief Business Officer at Lundbeck Seattle BioPharmaceuticals, Inc. and Research Associate at DNAX Research, Inc. He received a doctorate from the University of Stockholm, an MBA from Santa Clara University and an undergraduate degree from the University of California, Santa Cruz.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
15-02-2024 164 086 ( 0.43% ) 631 731 $ 29-02-2024

Actieve functies van Mark Litton

BedrijvenFunctieBegin
ATHIRA PHARMA, INC. Chief Executive Officer 16-06-2021
Director/Board Member -
Alle actieve functies van Mark Litton

Eerdere bekende functies van Mark Litton

BedrijvenFunctieEinde
ALPINE IMMUNE SCIENCES, INC. President 16-04-2019
ALDER BIOPHARMACEUTICALS, INC. Founder 01-08-2018
Corporate Officer/Principal 01-01-2004
Corporate Officer/Principal 01-01-1999
DNAX Research, Inc. Corporate Officer/Principal 01-01-1994
Ervaring van Mark Litton in detail bekijken

Opleiding van Mark Litton

Santa Clara University Masters Business Admin
University of California, Santa Cruz Undergraduate Degree
University of Stockholm Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Mark Litton in detail bekijken

Connecties

100 +

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven2
ATHIRA PHARMA, INC.

Health Technology

ALPINE IMMUNE SCIENCES, INC.

Health Technology

Bedrijven in privébezit6

Commercial Services

Health Technology

Chiroscience Group Plc

Commercial Services

Health Technology

DNAX Research, Inc.

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Mark Litton